The Liraglutide Effect and Action in Diabetes (LEAD) series were 6 phase 3 RCT that showed improvement in hemoglobin A1c levels, enhanced beta cell function, weight loss, and reduced blood pressure with liraglutide alone or in combination with other oral hypoglycemic agents
Potential biomarkers associated with the risk of developing PCa that showed statistically significant associations, grouped by functional group and by country
Nutrients, 10 (12), 1892
Achn Buil, B., Tackenberg, C., Rust, R., 2023
Zamil DH, Ameri M, Fu S, Abughosh FM, Katta R
This section digs into the four major degradation pathways that affect reconstituted peptides